Oura, the manufacturer of health-tracking smart rings, has officially suspended its plans for an initial public offering (IPO) just over a week after filing documents to list on the Nasdaq. The company, which had aimed for a valuation of $15bn, stated that the decision was driven by current instability within the IPO market.
The firm had initially intended to raise as much as $2.2bn by pricing shares between $40 and $44. However, Oura joins a growing list of companies, including Holtec International, that have recently retreated from public listings. Market analysts point to a challenging environment characterized by rising interest rates, global trade tensions, and inflationary pressures as primary factors dampening investor confidence.
Oura CEO Tom Hale described the IPO as merely one phase of the company's development, noting that the firm has the flexibility to wait for a more favorable climate. Despite the delay, the company reported financial growth, with pre-tax income reaching $70m on $1.2bn in sales for the nine-month period ending June 30.
The postponement occurs as the company faces a class-action lawsuit filed in August by the Clarkson Law Firm. The legal challenge alleges that Oura’s marketing claims regarding the accuracy of its sleep-tracking technology are misleading. Oura has denied these allegations, with a spokesperson stating, "We stand behind our science, research and accuracy claims," and emphasizing that the device uses multiple physiological signals to estimate sleep stages. It is understood that the litigation is not the cause of the decision to delay the stock market debut.
Source: BBC News
No comments yet. Be the first to share your thoughts.